Cited by 141Hepatocellular Carcinoma Treatment and PrognosisEstrogen and related hormone effectsProstate Cancer Treatment and Research

Role of sex steroid receptors in pathobiology of hepatocellular carcinoma

Open access
Kalra, Mamta, Mayes, Jary, Assefa, Senait, Kaul, Anil K, Kaul, Rashmi·2008·World Journal of Gastroenterology

Abstract

The striking gender disparity observed in the incidence of hepatocellular carcinoma (HCC) suggests an important role of sex hormones in HCC pathogenesis. Though the studies began as early as in 1980s, the precise role of sex hormones and the significance of their receptors in HCC still remain poorly understood and perhaps contribute to current controversies about the potential use of hormonal therapy in HCC. A comprehensive review of the existing literature revealed several shortcomings associated with the studies on estrogen receptor (ER) and androgen receptor (AR) in normal liver and HCC. These shortcomings include the use of less sensitive receptor ligand binding assays and immunohistochemistry studies for ERalpha alone until 1996 when ERbeta isoform was identified. The animal models of HCC utilized for studies were primarily based on chemical-induced hepatocarcinogenesis with less similarity to virus-induced HCC pathogenesis. However, recent in vitro studies in hepatoma cells provide newer insights for hormonal regulation of key cellular processes including interaction of ER and AR with viral proteins. In light of the above facts, there is an urgent need for a detailed investigation of sex hormones and their receptors in normal liver and HCC. In this review, we systematically present the information currently available on androgens, estrogens and their receptors in normal liver and HCC obtained from in vitro, in vivo experimental models and clinical studies. This information will direct future basic and clinical research to bridge the gap in knowledge to explore the therapeutic potential of hormonal therapy in HCC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3748/wjg.14.5945

Cites

162 of 162 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Androgens play a crucial role in the development of hepatocellular carcinoma.

    “androgens have been shown to play a crucial role in the development of hepatocellular carcinoma (Kalra et al., 2008, Kanda et al., 2014).”

    From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Kalra et al., 2008

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 14

  1. Nagasue N, Ito A, Yukaya H, Ogawa Y. Estrogen receptors in hepatocellular carcinoma. Cancer 1986; 57: 87-91 14
  2. Nagasue N, Kohno H, Chang YC, Hayashi T, Utsumi Y, Nakamura T, Yukaya H. Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women. Cancer 1989; 63: 112-116 16
  3. Nagasue N, Kohno H, Chang YC, Yamanoi A, Nakamura T, Yukaya H, Hayashi T. Clinicopathologic comparisons b e t w e e n e s t r o g e n r e c e p t o r -p o s i t i v e a n d -n e g a t i v e hepatocellular carcinomas. Ann Surg 1990; 212: 150-154
  4. Nagasue N, Kohno H, Yamanoi A, Kimoto T, Chang YC, Nakamura T. Progesterone receptor in hepatocellular carcinoma. Correlation with androgen and estrogen receptors. Cancer 1991; 67: 2501-2505 37
  5. Leygue E, Dotzlaw H, Watson PH, Murphy LC. Altered e s t r o g e n r e c e p t o r a l p h a a n R N A expression during human breast tumorigenesis. Cancer Res 1998; 58: 3197-3201
  6. Nagasue N, Chang YC, Hayashi T, Galizia G, Kohno H , N a k a m u r a T , Y u k a y a H . A n d r o g e n r e c e p t o r i n hepatocellular carcinoma as a prognostic factor after hepatic resection. Ann Surg 1989; 209: 424-427
  7. Engstrom PF, Levin B, Moertel CG, Schutt A. A phase II trial of tamoxifen in hepatocellular carcinoma. Cancer 1990; 65: 2641-2643
  8. www.wjgnet.com Biophys Res Commun 2001; 286: 1059-1065
  9. Chen JQ, Yager JD, Russo J. Regulation of mitochondrial respiratory chain structure and function by estrogens/ e s t r o g e n r e c e p t o r s a n d p o / pathophysiological implications. Biochim Biophys Acta 2005; 1746: 1-17 111
  10. Brandt S, Heller H, Schuster KD, Grote J. The tamoxifen- i n d u c e d s u p p r e s s i o n o f human hepatoblastoma cell line HepG2: a result of post- translational regulation. J Cancer Res Clin Oncol 2005; 131: 120-128 116
  11. Park YN, Chae KJ, Kim YB, Park C, Theise N. Apoptosis and proliferation in hepatocarcinogenesis related to cirrhosis. Cancer 2001; 92: 2733-2738 121
  12. P i e a s R J , S z e g o C M . P a r t i a l p u r i f i c a t i o n a n d characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes. Biochem J 1980; 191: 743-760 130
  13. Chen J, Li Y, Lavigne JA, Trush MA, Yager JD. Increased m i t o c h o n d r i a l s u p e r o x i mitochondria, rat hepatocytes, and HepG2 cells following ethinyl estradiol treatment. Toxicol Sci 1999; 51: 224-235 138
  14. Moats RK 2nd, Ramirez VD. Electron microscopic v i s u a l i z a t i o n o f m e m b r a n e -m e d i a translocation of estrogen-BSA:colloidal gold by hep G2 cells. J Endocrinol 2000; 166: 631-647 141

Cited by

Sorted by citations

Authors
Kalra, M., Mayes, J., Assefa, S., Kaul, A. K., & Kaul, R.
Affiliations
Johannes Gutenberg University Mainz (DE)
Corresponding author
Kaul, Rashmi
Venue
World Journal of Gastroenterology
Published
2008
Volume
14
Issue
39
Pages
5945
ISSN
1007-9327 (ISSN-L)
OpenAlex
W2153047557
Cited by
141
References
162
Citations by year
2026: 4 · 2025: 5 · 2024: 2 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 10 · 2019: 9 · 2018: 4 · 2017: 15 · 2016: 7 · 2015: 15 · 2014: 6 · 2013: 11 · 2012: 10
FWCI
0.64
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • World Journal of Gastroenterology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
Keywords
hepatocellular carcinoma, sex steroid receptors, estrogen receptor alpha, estrogen receptor beta, androgen receptor, sex hormones, hormone therapy, liver cancer pathogenesis, viral hepatitis, hepatoma cells
MeSH terms
Androgens, Animals, Disease Models, Animal, Estrogens, Female, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Receptors, Androgen, Receptors, Estrogen, Sex Characteristics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review